Archives: Contractor Email

This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

CPNI Community Pharmacy Patient Survey

As we enter the second half of the CPNI Community Pharmacy Patient Survey period it is encouraging to see pockets of high patient engagement emerging.  To boost the results further, we would encourage any contractors and their teams who are still to fully engage with the survey to do so immediately after the Easter break and for those actively pushing the survey to continue doing so by engaging counter staff to invite patients to participate in the survey.  With your cooperation and support we will be able to maximise response rates and strengthen the evidence gathered.

Living Well Service

  • The first campaign of 26/27 ‘Care in the Sun‘ started on 1 April 2026 and will run for two months.
  • Contractors providing the service can view the social media schedule and other campaign resources here.
  • Resource packs should have been received at this stage, if you have any queries in relation to delivery, please contact reception.pha@hscni.net and ensure your email subject heading is titled “LIVING WELL PHARMACY CAMPAIGN”.
  • The Living Well Schedule for 26/27 can be viewed here.
  • Campaign Summary reports on the Living Well service are published on the BSO website and detail the important interventions made by community pharmacy teams throughout the Living Well service.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
LIVING WELL CAMPAIGN SURVEY
**FOR THE ATTENTION OF LIVING WELL PHARMACIES ONLY**
Dear Contractor
Correspondence has been issued by SPPG on 03 April 2026 regarding the launch of the Living Well survey for the campaign ‘Immunise, protect, thrive’.

SUMMARY

  • The survey for the campaign ‘Immunise, protect, thrive’ is open and can be accessed here.
  • The survey must be completed by 6pm on Friday 8th May 2026.  Please ensure to reach the final screen to confirm submission.
  • Note: You may wish to take a screen shot of the final screen for your own records.

ACTION

  • Contractors are asked to review the SPPG correspondence issued on 03 April 2026 and share with all relevant members of the pharmacy team.

For any further information please contact your SPPG pharmacy advisor or a member of the CPNI team.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The following concessionary prices granted in March 2026 have rolled over to April 2026:
DrugPack SizeConcessionary Price
Apixaban 2.5mg tablets60£1.64
Lacosamide 200mg tablets56£4.42

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
The Pharmaceutical Society of Northern Ireland (PSNI) issued email correspondence to pharmacists, dated 2 April 2026, regarding changes to the upcoming annual pharmacist retention process. Changes include an increased fee, payment by instalment, and the method by which fee notifications can be issued.

SUMMARY

  • Details of the changes to pharmacist retention are available in the PSNI correspondence.
  • As a result of the legislative change described in the PSNI correspondence, the 2026-27 retention fee will be £477.
  • Pharmacists will have an option to pay via quarterly instalments.
  • Notifications for retention will be sent to the email address that registrants have issued to the Society.
  • It is planned that the retention window will open on 05 May 2026 and close on 31 May 2026.

ACTION

  • Contractors should review the PSNI correspondence, and share with relevant members of the pharmacy team.

Should you have queries regarding pharmacist registration or retention, you may wish to contact PSNI by email: info@psni.org.uk or phone: 028 9032 6927.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
NICPLD issued email correspondence dated 2 April 2026 to the Responsible Individuals (RI) for pharmacy contractors involved in FTY 2026/2027.  The correspondence provides updates regarding the training requirements for supervisors and trainees.

SUMMARY

ACTION

  • Contractors involved in FTY 2026/2027 should review the information above, and liaise with the nominated Responsible Individual, Educational Supervisor(s) and any other relevant members of the pharmacy team.

Should you wish to speak to a member of the CPNI team regarding FTY, please email Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The final update of concessionary prices were granted today for March 2026:
DrugPack SizeConcessionary Price
Apixaban 2.5mg tablets60£1.64
Apixaban 5mg tablets56£2.29
Nefopam 60mg tablets60£20.09
Nifedipine 5mg capsules90£44.80

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive